This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Neptune Wellness Solutions Valuation
Is NEPT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6
Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NEPT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate NEPT's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate NEPT's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NEPT?
Key metric: As NEPT is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for NEPT. This is calculated by dividing NEPT's market cap by their current
revenue.
What is NEPT's PS Ratio?
PS Ratio
0.3x
Sales
US$48.80m
Market Cap
US$12.20m
NEPT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: NEPT is good value based on its Price-To-Sales Ratio (0.3x) compared to the Canadian Personal Products industry average (3x)
Price to Sales Ratio vs Fair Ratio
What is NEPT's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
NEPT PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
0.3x
Fair PS Ratio
0.5x
Price-To-Sales vs Fair Ratio: NEPT is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.